Compare MVST & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MVST | CNXU |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | 1908 | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.7M | 215.9M |
| IPO Year | N/A | N/A |
| Metric | MVST | CNXU |
|---|---|---|
| Price | $0.91 | $7.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 5.4M | 132.8K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.55 | N/A |
| Revenue Next Year | $17.08 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $7.10 |
| 52 Week High | $7.12 | $13.66 |
| Indicator | MVST | CNXU |
|---|---|---|
| Relative Strength Index (RSI) | 35.06 | 42.74 |
| Support Level | $0.71 | $7.62 |
| Resistance Level | $1.38 | $11.51 |
| Average True Range (ATR) | 0.06 | 1.20 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 29.47 | 42.15 |
Microvast Holdings Inc develops lithium-ion battery technologies focused on high-performance solutions for commercial and industrial electrification. The Company designs, develops, and manufactures battery components and systems for electric commercial vehicles and energy storage systems (ESS), with applications across buses, trucks, port equipment, and mining machinery. It emphasizes innovation in battery design without relying on legacy technologies and supports platforms such as the IVECO eDaily and various bus models. The Company also provides services, repairs, and warranty and extended warranty support. It operates as a single reportable segment, covering design, development, manufacturing, sales, and leasing of battery systems, and generates the majority of its revenue from Europe.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.